Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ketone doai
Reexamination Certificate
2007-10-16
2007-10-16
Oh, Taylor Victor (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ketone doai
C514S715000, C514S724000
Reexamination Certificate
active
11084316
ABSTRACT:
The invention provides methods for treating beta-Amyloid protein-induced disease, pharmaceutical compositions and compounds useful for the same, and the use of these compounds for the manufacture of a medicament for treating the same. More particularly, the invention relates to the use of natural product compounds isolated from turmeric,gingko biloba, and ginger, and synthetic chemical analogues thereof, for the treatment of a beta-Amyloid protein-induced disease.
REFERENCES:
patent: 5089636 (1992-02-01), Kwak et al.
patent: 5266344 (1993-11-01), Mimura et al.
patent: 5587358 (1996-12-01), Sukigara et al.
patent: 02-193930 (1990-07-01), None
patent: 07206669 (1995-08-01), None
patent: 08-040970 (1996-02-01), None
patent: 11246398 (1999-09-01), None
patent: WO 97/03674 (1997-02-01), None
patent: WO 98/51302 (1998-11-01), None
patent: WO 00/70949 (2000-11-01), None
Locksley et al , Perkin Transactions1: J. of The Chemical Society, 1972, 23, p. 3001-3006.
Beard, et al., “Nonsteroidal Anti-Inflammatory Drug Use and Alzheimer's Disease: A Case-Control Study in Rochester, MN 1980-1984,”Mayo Foundation for Medical Education and Research73(10), 951-955 (1998).
Behl et al., “Hydrogen Peroxide Mediates Amyloid β Protein Toxicity,”Cell77, 817-827 (1994).
Carr, et al., “Current Concepts in the Pathogenesis of Alzheimer's Disease,”The American Journal of Medicine, 103(3A), 3S-10S (1997).
Cuajungco, et al., “Zinc Metabolism in the Brain: Relevance to Human Neurodegenerative Disorders,”Neurobiology of Disease4, 137-169 (1997).
Davis, et al., “The Amyloid Beta-Protein of Alzheimer's Disease is Chemotactic for Mononuclear Phagocytes,”Biochemical and Biophysical Research Communications189(2) 1096-1100 (1992).
Friedlich et al., “Involvement of Free Oxygen Radicals in β-Amyloidosis: An Hypothesis,”Neurobiology of Aging15(4), 443-455 (1994).
Ghanta et al., “A Strategy for Designing Inhibitors of β-Amyloid Toxicity,”The Journal of Biological Chemistry271(47): 29525-29528 (1996).
Goedert, “Tau protein and the neurofibrillary pathology of Alzheimer's disease,”TINS16(11) 460-465 (1993).
Green et al., “Nuclear Estrogen Receptor-Independent Neuroprotection by Estratrienes: A Novel Interaction with Glutathione,”Neuroscience84(1), 7-10 (1998).
Haass et al., “Cellular Processing of β-Amyloid Precursor Protein and the Genesis of Amyloid β-Peptide,”Cell75 10-39-1042 (1993).
Harkany et al., “Cholinotoxic effects of β-amyloid(1-42)peptide on cortical projections of the rat nucleusBasalis magnocellularis,” Brain Research695, 71-75 (1995).
Hefti, “Development of Effective Therapy for Alzheimer's Disease Based on Neurotrophic Factors,”Neurobiology of Aging15(2), S193-S194 (1994).
Henderson, “The epidemiology of estrogen replacement therapy and Alzheimer's disease,”American Academy of Neurology48(5), S. 7, 275-355 (1997).
Hensley et al., “A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: Relevance to Alzheimer disease,”PNAS USA91, 3270-3274 (1994).
Hertel et al., “Inhibition of the electrostatic interaction between β-amyloid peptide and membranes prevents β-amyloid-induced toxicity,”PNAS USA94, 9412-9417 (1997).
Hidalgo et al., “Determination of the Carnosic Acid Content in Wild and CultivatedRosmarinus officinalis,” J. Agric. Food. Chem46, 2624-2627 (1998).
Hopia et al., “Effect of Different Lipid Systems on Antioxidant Activity of Rosemary Constituents Carnosol and Carnosic Acid with and without α-Tocopherol,”J. Agric. Food Chem44, 2030-2036 (1996).
Hoshi et al., “Nontoxic Amyloid β Peptide1-42Suppresses Acetylocholine Synthesis,”The Journal of Biological Chemistry272(4), 2038-2041 (1997).
Ihara et al., “Phosphorylated Tau Protein Is Integrated into Paired Helical Filaments in Alzheimer's Disease,”J. Biochem99, 1807-1810 (1986).
Jitoe et al., “Antioxidant Activity of Tropical Ginger Extracts and Analysis of the Contained Curcuminoids,”J. Agric. Food Chem40, 1337-1340 (1992).
Kiegeris et al., “Activation of Macrophages by Alzheimer β Amyloid Peptide,”Biochemical and Biophysical Research Communications199(2), 984-991 (1994).
Kihara et al., “Stimulation of α4β2 nicotinic acetylcholine receptors inhibits β-amyloid toxicity,”Brain Research792, 331-334 (1998).
Kikuzaki et al., “Antioxidant Effects of Some Ginger Constituents,”Journal of Food Science58(6), 1407-1410 (1993).
Kim et al., “Shogaols fromZingiber officinaleProtect IMR32 Human Neuroblastoma and Normal Human Umbilical Vein Endothelial Cells from β-Amyloid (25-35) Insult,”Letter . . . Planta Med 200268, 375-376 (2002).
Kumar et al., “The Acute Neurotoxic Effect of β-Amyloid on Mature Cultures of Rat Hippocampal Neurons is Attenuated by the Anti-Oxidant U-78517F,”Intern. J. Neuroscience79, 185-190 (1994).
Lahiri et al., “Tacrine Alters the Secretion of the Beta-Amyloid Precursor Protein in Cell Lines,”Journal of Neuroscience Research37: 777-787 (1994).
Lorenzo et al., “Amyloid Fibril Toxicity in Alzheimer's Disease and Diabetesα”,Annals New York Academy of Sciences: 89-95.
Lucca et al., “Influence of cell culture conditions on the protective effect of antioxidants against β-amyloid toxicity: studies with lazaroids,”Brain Research764: 2930298 (1997).
Manelli et al., “β-Amyloid-Induced Toxicity in Rat Hippocampal Cells: In Vitro Evidence for the Involvement of Free Radicals,” Brain Research Bulletin 18(6): 569-576 (1995).
Mattson, “Neuroprotective Signal Transduction: Relevance to Stroke,”Neurosci Biobehav Rev21(2): 193-206 (1997).
Maurice et al., Amnesia induced in mice by centrally administers β-amyloid peptides involves cholinergic dysfunction,Brain Research706:181-193 (1996).
Müller et al. “Protection of Flupertine on β-Amyloid-Indiced Apoptosis in Neuronal Cells In Vitro: Prevention of Amyloid-Induced Glutathion Depletion,”Journal of Neurochemistry68(6):2371-2377 (1997).
Nakatani et al., “A New Diterpene Lactone, Rosmadial, from Rosemary (Rosmarinus officinalisL.),”Agric. Biol. Chem. 47(2):353-358 (1983).
Park et al., “Discovery of Natural Products fromCurcuma longathat Protect Cells from Beta-Amyloid Insult: A Drug Discovery Effort Against Alzheimer's Disease,”Journal of Natural Products65(9):1227-1231 (2002).
Parnetti et al., “Cognitive Enhancement Therapy for Alzheimer's Disease,”Drugs53(5): 752-768 (1997).
Pasinetti et al., “Cyclooxygenase-2 Expressiosn is Increased in Frontal Cortex of Alzheimer's Disease Brain,”Neuroscience87(2):319-3224 (1998).
Pike et al., “Neurodegeneration Induced by β-Amyloid Peptides in vitro: The Role of Peptide Assembly State,”The Journal of Neuroscience13(4) 1676-1687 (1993).
Pike et al., “β-Amyloid Neurotoxicity In Vitro: Evidence of Oxidative Stress but Not Protection. by Antioxidants,”Journal of Neurochemistry69(4):1601-1611 (1997).
Pollack et al., “Sulfonated dyes attenuate the toxic effects of β-amyloid in a structure-specific fashion,”Neuroscience Letters197: 211-214 (1995).
Preston et al., “Toxic effects of β-amyloid(25035) on immortalized rat brain endothelian cell: protection by carnosine, homecarnosine and β-alanine,”Neuroscience Letters242: 105-108 (1998).
Puttfarcken et al., “Inhibition of Age-Induced β-Amyloid Neurotoxicity in Rat Hippocampal Cells,”Experimental Neurology138: 73-81 (1996).
Seidl et al., “Evidence against increased glycoxidation in patients with Alzheimer's disease,”Neuroscience Letters232, 49-52 (1997).
Seiger et
LandOfFree
Pharmaceutical compositions useful in prevention and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions useful in prevention and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions useful in prevention and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3840633